Marc N. Casper - Feb 9, 2023 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Stock symbol
TMO
Transactions as of
Feb 9, 2023
Transactions value $
-$19,738,693
Form type
4
Date filed
2/13/2023, 03:35 PM
Previous filing
Nov 18, 2022
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Gift $0 -1K -0.63% $0.00 157K Feb 6, 2023 Direct
transaction TMO Common Stock Gift $0 -3.3K -2.1% $0.00 154K Feb 6, 2023 Direct
transaction TMO Common Stock Gift $0 +3.3K $0.00 3.3K Feb 6, 2023 By Spouse
transaction TMO Common Stock Gift $0 -5K -3.25% $0.00 149K Feb 6, 2023 Direct
transaction TMO Common Stock Gift $0 +5K $0.00 5K Feb 6, 2023 By MNC 2020 Irrevocable Trust F1
transaction TMO Common Stock Options Exercise $1.58M +10K +6.72% $157.68 159K Feb 9, 2023 Direct
transaction TMO Common Stock Sale -$1.17M -2.06K -1.3% $568.44 157K Feb 9, 2023 Direct F2, F3
transaction TMO Common Stock Sale -$456K -800 -0.51% $569.46 156K Feb 9, 2023 Direct F2, F4
transaction TMO Common Stock Sale -$751K -1.32K -0.84% $570.49 155K Feb 9, 2023 Direct F2, F5
transaction TMO Common Stock Sale -$343K -600 -0.39% $571.60 154K Feb 9, 2023 Direct F2, F6
transaction TMO Common Stock Sale -$744K -1.3K -0.84% $572.65 153K Feb 9, 2023 Direct F2, F7
transaction TMO Common Stock Sale -$861K -1.5K -0.98% $573.75 151K Feb 9, 2023 Direct F2, F8
transaction TMO Common Stock Sale -$575K -1K -0.66% $574.68 150K Feb 9, 2023 Direct F2, F9
transaction TMO Common Stock Sale -$1.5M -2.6K -1.73% $575.77 148K Feb 9, 2023 Direct F2, F10
transaction TMO Common Stock Sale -$1.5M -2.6K -1.76% $576.69 145K Feb 9, 2023 Direct F2, F11
transaction TMO Common Stock Sale -$1.12M -1.94K -1.34% $578.23 143K Feb 9, 2023 Direct F2, F12
transaction TMO Common Stock Sale -$289K -500 -0.35% $578.77 142K Feb 9, 2023 Direct F2, F13
transaction TMO Common Stock Sale -$929K -1.6K -1.12% $580.92 141K Feb 9, 2023 Direct F2, F14
transaction TMO Common Stock Sale -$809K -1.39K -0.99% $581.90 140K Feb 9, 2023 Direct F2, F15
transaction TMO Common Stock Sale -$466K -800 -0.57% $582.79 139K Feb 9, 2023 Direct F2, F16
transaction TMO Common Stock Options Exercise $1.58M +10K +7.21% $157.68 149K Feb 10, 2023 Direct
transaction TMO Common Stock Sale -$564K -1K -0.67% $564.12 148K Feb 10, 2023 Direct F2, F17
transaction TMO Common Stock Sale -$282K -500 -0.34% $564.79 147K Feb 10, 2023 Direct F2, F18
transaction TMO Common Stock Sale -$340K -600 -0.41% $566.48 147K Feb 10, 2023 Direct F2, F19
transaction TMO Common Stock Sale -$573K -1.01K -0.69% $567.42 146K Feb 10, 2023 Direct F2, F20
transaction TMO Common Stock Sale -$2.54M -4.48K -3.07% $568.64 141K Feb 10, 2023 Direct F2, F21
transaction TMO Common Stock Sale -$3.23M -5.68K -4.02% $569.59 135K Feb 10, 2023 Direct F2, F22
transaction TMO Common Stock Sale -$2.96M -5.2K -3.84% $570.62 130K Feb 10, 2023 Direct F2, F23
transaction TMO Common Stock Sale -$883K -1.55K -1.19% $571.31 129K Feb 10, 2023 Direct F2, F24

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -7.91% $0.00 116K Feb 9, 2023 Common Stock 10K $157.68 Direct F25
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10K -8.59% $0.00 106K Feb 10, 2023 Common Stock 10K $157.68 Direct F25
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.96 to $568.95, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23) and (24) to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.01 to $569.81, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.01 to $570.97, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.08 to $571.88, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $572.10 to $572.98, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $573.12 to $574.11, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $574.12 to $575.02, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $575.12 to $576.09, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $576.17 to $577.10, inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $577.64 to $578.63, inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $578.64 to $578.96, inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $580.41 to $581.38, inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $581.48 to $582.265, inclusive.
F16 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $582.50 to $583.08, inclusive.
F17 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $563.495 to $564.36, inclusive.
F18 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $564.60 to $565.21, inclusive.
F19 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $566.01 to $566.94, inclusive.
F20 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $567.20 to $567.78, inclusive.
F21 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.06 to $569.04, inclusive.
F22 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $569.06 to $570.05, inclusive.
F23 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $570.11 to $571.07, inclusive.
F24 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $571.11 to $571.56, inclusive.
F25 The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.

Remarks:

One of two Form 4's filed on February 13, 2023 for the reporting of transactions occurring on February 9, 2023 and February 10, 2023. The second Form 4 includes additional indirect holdings that could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4.